Search
Searching Content indexed under Intellectual Property by Antoinette Konski ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5  
>>Next
 
Title
Country
Organisation
Author
Date
1
Personalized Therapy Patent Falls As Patent-Ineligible
In a non-precedential opinion, the Federal Circuit held as patent-ineligible patent claims to personalized therapy to treat patients who would benefit from inhaled nitric oxide treatment
United States
12 Sep 2019
2
Statements Of Efficacy And Safety Material Claim Limitations
In Allergan Sales, LLC v. Sandoz, Inc., (Fed. Cir. 2018-2207, Aug. 29, 2019), the Federal Circuit held that "wherein" clauses in a patent claim were limitations
United States
4 Sep 2019
3
Federal Circuit Invalidates Patented Cancer Therapy
In BTG International Limited v. Amneal Pharmaceuticals LLC, (Fed. Cir. Slip Op. 2019-1147, May 14, 2019), the Federal Circuit held that U.S. Patent No. 8,822,438 ("the ‘438 Patent") was invalid as obvious over the prior art.
United States
30 May 2019
4
Is 101 Relief In Sight?
Senators Thom Tillis (R-N.C.) and Chris Coons (D-Del.) released a plan to revise Section 101 of Title 35 of the U.S. Code relating to U.S. patent law,
United States
3 May 2019
5
New Guidance From Federal Circuit For Computer-Implemented Medical Methods
A patent claiming methods to integrate physiological treatment data remotely using a computer was held invalid under 35 U.S.C. § 101
United States
19 Mar 2019
6
USPTO Patent Eligibility Training On 2019 Revised Subject Matter Guidance
On February 28, 2019, the USPTO summarized and explained the recently issued 2019 Revised Patent Subject Matter Eligibility Guidance
United States
12 Mar 2019
7
USPTO Releases 2019 Eligibility Update
The Guidance takes effect Monday, January 7, 2019.
United States
10 Jan 2019
8
Diagnostic Method Claims And Primer Tools Lack Patent-Eligibility
The decision summarizes this panel's current thinking on the patent-eligibility of unmodified polynucleotides and methods to detect "natural phenomena" using "conventional" tools.
United States
23 Oct 2018
9
Medical Treatment Patent Claims Held Patentable Subject Matter Under The Alice/Mayo Section 101 Test
In Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals Int'l Ltd, Slip Op. (Nos. 2016-2707, 2016-2708, April 13, 2018) the U.S. Court of Appeals ...
United States
29 May 2018
10
USPTO Update On Patent-Eligibility For Life Science Inventions
On August 2nd 2017, the USPTO hosted a Bicoastal Biotechnology/Chemical/Pharmaceutical Customer Partnership that focused on the USPTO's current thinking on patent-eligibility.
United States
29 Sep 2017
11
Why The Federal Circuit Revisited Written Description
In Stanford University v. The Chinese University of Hong Kong, the Federal Circuit vacated and remanded interference decisions on the ground the PTAB applied the incorrect standard in determining ...
United States
20 Jul 2017
12
USPTO Extends Cancer Immunotherapy Pilot Program
On June 29th, 2016, the USPTO announced the Cancer Immunotherapy Pilot Program to allow expedited examination of patent applications that pertain to cancer immunotherapy.
United States
29 Jun 2017
13
Federal Circuit's Primer On Equivalence Infringement Of Chemical Process Patents
In an appeal characterized as "unusual," the Federal Circuit affirmed the grant of a preliminary injunction, holding it likely that plaintiff patent holder would succeed on the merits its claim...
United States
23 May 2017
14
One Is Not Enough – Infringement Liability Under § 271(F)(1)
The Court's decision is important for manufacturers of kit components and those that license and aggregate those components into a single commercial kit.
United States
15 Mar 2017
15
Federal Circuit Knocks Out Patents After CBM Challenge
Apple successfully invalidated three patents for failure to recite patent eligible subject matter.
United States
21 Feb 2017
16
Inherent Disclosure Satisfied Written Description
The Federal Circuit held that a claim to an isolated protein described by its partial amino acid sequence satisfies 35 U.S.C. § 112 when the partial sequence is combined with other identifying characteristics of the protein.
United States
23 Sep 2016
17
USPTO Announces Cancer Moonshot Challenge
The challenge concludes on September 12th and winners will be announced on September 26th, 2016.
United States
31 Aug 2016
18
Ariosa Loses Verinata Patent Challenge
Fetal diagnostic pioneer Ariosa Diagnostics lost its latest attempt to invalidate competitor Verinata Health's U.S. Patent No. 8,318,430, "Methods of Fetal Abnormality Detection." The USPTO's Patent Trial and Appeal Board (PTAB) concluded that Petitioner Ariosa Diagnostics (Ariosa) failed to demonstrate the unpatentability of challenged claims 1-30. Ariosa Diagnostics, Inc. v. Verinata Health, Inc., IPR2013-0027/-00277 (PTAB Aug. 15, 2016).
United States
31 Aug 2016
19
Federal Circuit's Recent Primer On Patent-Eligibility
A method of producing a desired population of multi-cryopreserved hepatocytes was held to be patent-eligible because the challenged claims did not recite a judicial exception.
United States
8 Jul 2016
20
Supreme Court Declines Sequenom Review
The '540 Patent was awarded to inventors Yuk-Ming Dennis Lo and James Stephen Wainscot for "Non-invasive prenatal diagnosis."
United States
7 Jul 2016
Links to Result pages
 
1 2 3 4 5  
>>Next